The mission of the ATLAS Research Initiative is to accelerate health research and medical breakthroughs, by UCLA researchers, which will result in individualized preventative care and treatement.
Biobanking refers to the systematic collection and storage of a large number of biospecimens (blood, saliva, tissue, etc.) from patients as a resource for later clinical research. Biobanked samples provide a repository of DNA, proteins or mRNAs useful to answer diagnostic or treatment questions well before those questions are even posed, and as such are a cornerstone of research into individualized care.
Our Biobank analyzes the DNA of patient-participants. Signing up is easy:
Watch a 5 minute informational consent video and answer a few questions. You will need your UCLA Medical Record Number to complete the consent.
You can sign the consent form and opt in using the iPad located at various UCLA Health clinic locations across Los Angeles.
On your next visit to the lab, we will save your left over biological samples and clinical data or draw an addtional sample for use in the program. Follow the link for Frequenty Asked Questions.
The UCLA Health ATLAS Initiative aims to create a genetic map of UCLA patients, enabling us to find new risk factors for diseases and choose the best treatments for each patient.
The California Center for Rare Diseases provides advanced diagnosis and treatment to this underserved population
Cardiovascular Genetics Clinic takes a pioneering approach in viewing a patient’s cardiovascular health holistically, tailoring care to match both lifestyle and genetics.
CART is the leading autism center in the U.S., with a history of developing new behavioral therapies and breakthroughs in neurogenetics and autism research.
CNRC is renowned for its excellence in the diagnosis and care for people with brain diseases, such as Parkinson’s, Alzheimer’s, migraine, and stroke.
“There is no better example of precision medicine than having your own immune system eradicate a cancer. We’re able to make that possible, now.”
—Antoni Ribas, MD
Professor of Medicine, Surgery, and Molecular and Medical Pharmacology David Geffen School of Medicine at UCLA
